In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1861 News Items found
Photo of a man, woman, and child sitting outside smiling
Translating Science Into Cures: Bringing Fresh Hope to the Denisiuk Family

Mark Denisiuk was diagnosed with acute myeloid leukemia in the spring of 2021. He found hope when he enrolled in an early trial of an entirely new kind of drug that’s based on lab research conducted at MSK.
Memorial Sloan Kettering patient Rebecca Lerner smiling in the hospital
Unlocking a Mystery: What’s Behind the Rise In Colorectal Cancer Among Young People

Doctors and scientists at MSK are desperately trying to figure out why more young patients like Rebecca, 33, are getting colorectal cancer — and how best to treat them.
A Fred’s Team runner giving a high five
Your Impact: Celebrating Our Donors’ Support in 2021

Learn about how our donor community is funding life-changing cancer research at Memorial Sloan Kettering and ensuring a brighter future for people with cancer around the world.
Dana Pe'er
“Beautiful Patterns in Biology”: How SKI’s Dana Pe’er Earned a Top Honor and Advocates for Women Scientists

Read an interview with Sloan Kettering Institute Computational and Systems Biology Chair Dana Pe'er.
Physician-scientist Nai-Kong Cheung
Caging the Beast: MSK Researchers Design a New Radiation Treatment More Destructive to Cancer Cells

Learn about the work of Nai-Kong Cheung and other MSK scientists who have learned more about how to deliver stronger treatment with less toxicity.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Luis A. Diaz, MD, head of the division of Solid Tumor Oncology at MSK
Changing the Standard of Care at MSK and Beyond: New Treatment Option for Advanced Colorectal Cancer

A landmark study led in part by physician-researchers from Memorial Sloan Kettering is giving new hope to some people with metastatic colorectal cancer.
Lymphoma expert Gilles Salles
Q&A
Taking on New Challenges: 8 Questions with Gilles Salles

New Lymphoma Service Chief Gilles Salles discusses his plans for research and collaborations at MSK.
Kayvan Keshari
In the Lab
Fructose Could Play a Role in Targeting Leukemia

Leukemia cells metabolize fructose in a way that could make them easier to target with drugs.
Yi-Long Wu, President of CTONG, and Sir Murray Brennan, MSK’s Senior Vice President of International Programs; center: Honorable Kevin Rudd, 26th Prime Minister of Australia and 8th President and CEO of Asia Society; right (top to bottom): Lisa DeAngelis, MSK’s Physician-in-Chief and Chief Medical Officer, and Bob Li, MSK’s Physician Ambassador to China and Asia-Pacific
In the News
Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Strengthen International Collaboration During Annual Symposium

The initiative lays the groundwork for speedier cancer drug approvals in both the United States and China.